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The purpose of this study was to determine the impact of magnetic resonance 
imaging (MRI) geometric distortions when using MRI for target delineation and 
planning for whole-breast, intensity-modulated radiotherapy (IMRT). Residual 
system distortions and combined systematic and patient-induced distortions are 
considered. This retrospective study investigated 18 patients who underwent 
whole-breast external beam radiotherapy, where both CT and MRIs were acquired 
for treatment planning. Distortion phantoms were imaged on two MRI systems, 
dedicated to radiotherapy planning (a wide, closed-bore 3T and an open-bore 1T). 
Patient scans were acquired on the 3T system. To simulate MRI-based planning, 
distortion maps representing residual system distortions were generated via deform-
able registration between phantom CT and MRIs. Patient CT images and structures 
were altered to match the residual system distortion measured by the phantoms on 
each scanner. The patient CTs were also registered to the corresponding patient 
MRI scans, to assess patient and residual system effects. Tangential IMRT plans 
were generated and optimized on each resulting CT dataset, then propagated to 
the original patient CT space. The resulting dose distributions were then evalu-
ated with respect to the standard clinically acceptable DVH and visual assessment 
criteria. Maximum residual systematic distortion was measured to be 7.9 mm (95% 
< 4.7 mm) and 11.9 mm (95% < 4.6 mm) for the 3T and 1T scanners, respectively, 
which did not result in clinically unacceptable plans. Eight of the plans accounting 
for patient and systematic distortions were deemed clinically unacceptable when 
assessed on the original CT. For these plans, the mean difference in PTV V95 (vol-
ume receiving 95% prescription dose) was 0.13 ± 2.51% and -0.73 ± 1.93% for 
right- and left-sided patients, respectively. Residual system distortions alone had 
minimal impact on the dosimetry for the two scanners investigated. The combina-
tion of MRI systematic and patient-related distortions can result in unacceptable 
dosimetry for whole-breast IMRT, a potential issue when considering MRI-only 
radiotherapy treatment planning.
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I. INTRODUCTION
Magnetic resonance imaging (MRI) is being used more frequently in radiotherapy planning 
due to superior soft-tissue contrast.(1,2) While MRI remains investigational at the present time 
in breast planning, it potentially offers greater soft-tissue delineation than CT scans.(3) With the 
growing interest in the utilization of MRI for radiotherapy treatment planning, the geometric 
distortions associated with MRI require consideration.(4) Distortions due to nonlinearities in 
the gradient coils and inhomogeneities in the B0 field increase in magnitude with increasing 
distance from the MRI isocenter.(5) The patient introduces additional effects, such as chemical 
shift and susceptibility due to the variations in magnetic properties of different tissues. Although 
the implementation of vendor-supplied distortion correction algorithms can reduce the system-
related distortions, they are not completely removed.(6) Several methods can be utilized to 
correct for patient-specific distortions, including acquiring two images with reversed gradient 
direction(7) and B0 mapping;
(8) however, clinical implementation of these can be challenging and 
is not routinely implemented.(4) Acquiring images with a high imaging bandwidth (BW) can be 
used to minimize the distortions due to chemical shift and magnetic susceptibility. However, an 
increased BW results in a number of trade-offs including a reduced signal-to-noise ratio (SNR), 
which could be problematic in certain signal-challenging sites and acquisition techniques.(9)
Investigations into the dosimetric impact of MRI geometric distortions on the radiotherapy 
treatment planning (RTP) process have been conducted for brain and prostate patients. Brain 
studies focus on a small field of view (FOV) at the center of the scanner where distortions 
are minimal.(10,11) The prostate studies were conducted on low-magnetic field-strength scan-
ners,(12-14) or on phantom geometry.(15) Prott et al.(16) suggested that these effects may have 
more influence on breast cancer treatment, where the anatomy extends out into regions of higher 
geometrical inaccuracies.
The aim of this study was to investigate the effect of MRI geometric distortions on the 
dose distribution in tangential whole-breast, intensity-modulated radiation therapy (IMRT). 
The impact of residual system distortions alone was compared for two different scanners with 
different field strengths and configurations. The influence of the combined distortion arising 
from the system and the patient was also investigated on the higher field-strength system.
 
II. MATERIALS AND METHODS
A.  Phantom data
A.1 Image acquisition
Residual system distortion maps were obtained from two separate MRI scanners with different 
configurations and field strengths using specific phantoms.
An in-house developed 3D phantom comprising of vitamin E capsules within a plastic hous-
ing structure(5) was scanned on a closed, wide-bore 3T Siemens Magnetom Skyra (Siemens 
Medical Systems, Erlangen, Germany). A 2D spin echo sequence (voxel size 1.56 × 1.56 × 
2 mm3, 500 × 500 × 252 mm3 FOV, 445 Hz/pixel, TE/TR/flip angle 12 ms/2760 ms/90°) was 
acquired with vendor 2D distortion correction algorithm applied (to match acquired patient 
images — detailed below). The air-phantom interface had minimal impact on the distortion 
assessment in the region of interest for this study since the interface occurs at the FOV edges 
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and all patient anatomy is encompassed within this volume. A corresponding CT of this phantom 
was acquired to provide the undistorted geometry of the phantom.
Using a 1.0 T Panorama high-field open vertical-bore system (Philips Medical Systems, 
Best, The Netherlands), a vendor-supplied 3D distortion phantom consisting of docusate 
sodium capsules within a foam structure(17) was scanned using a 3D T1 spoiled gradient echo 
sequence (voxel size 0.938 × 0.938 × 2 mm3, 450 × 450 × 400 mm3 FOV, 385 Hz/pixel, TE/
TR/flip angle: 3.77 ms/30 ms/60°, 3D correction algorithm applied). A CT of this phantom was 
also acquired. Standard shimming was performed over the whole volume prior to each image 
acquisition on both scanners.
A.2  Quantification of residual system distortions
To quantify systematic distortions, the CT and MR phantom images from each scanner were 
registered. A robust rigid registration method(18) was applied to compensate for changes in 
position between modalities, then a deformable multiscale (four levels) B-spline registration 
algorithm(19) was used to account for nonlinear MRI deformations. To promote smoothness, 
the spacing of the final B-spline control point grid was adjusted by selecting the largest value 
that would allow accurate alignment of the phantom markers postregistration, as determined by 
visual assessment. We identified 25 mm and 10 mm as the best control point spacing parameters 
for registering MRI-CT images for the 3T and the 1T phantom images, respectively. The regis-
tration results were manually validated by verifying that the phantom markers were accurately 
aligned to within one voxel.(5)
B. Patient data
B.1 Image acquisition
Datasets for 18 patients who underwent whole-breast, external-beam radiotherapy (12 right-
sided, 6 left-sided) were obtained. The images were acquired for a breast MRI-CT contouring 
study and were retrospectively obtained for the purposes of this investigation. Patients were 
positioned on both CT and MRI using the same treatment simulation setup on a flat table and in 
a head-first supine position. Patients were set up on an MRI-compatible wing board (MTWB09 
Wingboard, CIVCO Medical Solutions, Orange City, IA) with no angular incline for both imag-
ing modalities. The patient position on the wing board was recorded per clinical practice for 
ensuring consistency between simulation and treatment. Noncontrast CT images were acquired 
on a Philips Brilliance Big Bore scanner (Philips Health Care, Cleveland, OH) (voxel size 
0.98 × 0.98 × 2 mm3, 500 × 500 mm2 FOV). Field length was determined on individual patient 
requirements. The MRI was acquired on the same day as CT, on the aforementioned 3T MRI 
scanner only for comparison with the acquired phantom images. T2-weighted 2D turbo spin 
echo images were acquired (voxel size 0.6 × 0.6 × 2 mm3, 400 × 400 mm2 to 450 × 450 mm2 
FOV, TE/TR/flip angle 83–88 ms/2480–7910 ms/150°–167°), with standard tune-up B0 shim-
ming localized to the imaging volume, per the study imaging protocol. Patients were requested 
to shallow-breathe during the image acquisition. The sequence acquired ran for 6 min/14 s. No 
ghosting was observed in these images, indicating minor effects of breathing motion. A standard 
18-channel surface coil was placed on top of foam coil bridges custom-designed within the 
department to ensure the coils did not displace the anatomy. Images were prospectively corrected 
using the vendor-supplied 2D gradient distortion correction algorithm (3D not available for 
the sequence utilized at commencement of study). The initial 10 patients were acquired with a 
pixel BW of 230 Hz/pixel to provide good SNR. The final eight patients were acquired with a 
pixel BW of 450 Hz/pixel, reducing patient distortions but at the expense of SNR.
Clinical target volume (CTV) and seroma volumes for each patient based on the CT images 
were contoured by an experienced radiation oncologist. Lung, heart, contralateral breast, and 
external patient volumes were contoured by an experienced senior planner.
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B.2  Quantification of residual systematic and patient-induced distortions
Distortion maps representing the combined residual systematic and patient-induced distortions 
were estimated by registering the patient CT images with the corresponding patient MRI (3T 
only). The deformable B-spline registration process used for the phantom images was also used 
for the patient data, but with a final control point grid spacing of 15 mm, which was found to 
give adequate accuracy at a realistic smoothness level over the entire FOV. Each registered 
image was visually assessed for accuracy, with particular focus around the breast and chest 
wall regions where anatomical landmarks (ribs, outer breast surface) were accurate to within 
1 voxel. To validate the deformable registration further, a 3D volume of the breast volume 
(incorporating the skin surface and the chest wall) was automatically segmented by thresholding 
in ITK-SNAP (version 3.4.0) for each dataset. The Dice similarity coefficient (DSC) was then 
calculated in MILXView for the volumes generated on the original planning CT and MRI, then 
compared with the DSC for the deformed CT and MRI. The DSC has a value of 1 for perfect 
agreement and 0 when no overlap is present.
C.  Image distortion
To investigate the impact of MRI geometric distortion, each patient CT (and corresponding contours) 
was distorted in three ways, using the phantom-computed distortion maps (3T and 1T) and using 
the combined residual system and patient-induced distortion maps (3T only) (Fig. 1). The phantom 
data allowed investigations on the potential dosimetric variations between MRI scanners of differ-
ent configurations in whole-breast RTP without the confounding factor of patient-induced effects. 
With the 3T, using both phantom- and patient-based distortion maps allowed for a comparison 
between the system-related effects and combined system and patient-related effects.
In all cases, contour variation was assessed for the CTV, seroma, contralateral breast, com-
bined lung, and heart volumes. The DSC was obtained between original and distorted contours 
to investigate their overlap using:
 DSC = 2 × [intersection volume / (original contour volume + 
  distorted contour volume)] (1)
Fig. 1. Methodology schematic showing the image distortion processes for the phantom and patient datasets.
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D.  Treatment planning
After registration, four different CT datasets were considered (Fig.1):
1.  The original CT,
2.  A CT dataset deformed according to the 3T residual system distortions,
3.  A CT dataset deformed according to the 1T residual system distortions, and
4.  A CT dataset nonrigidly registered to the patient geometry on the 3T.
Our study utilized a scripted tangential IMRT technique reflecting the current clinical prac-
tice of predominately tangential beams and the emerging trends of IMRT utilisation.(20,21) For 
each of the simulated CT datasets, inverse-planned hybrid IMRT plans were created using an 
automated script in Pinnacle Version 9.6 (Philips Radiation Oncology Systems, Milpitas, CA) 
to a prescription of 50 Gy in 25 fractions in accordance with standard clinical protocols. The 
script was designed to establish gantry angle and determine the field size and beam modulation, 
with limited degrees of freedom (maximum number of segments = 8, minimum segment area = 
9 cm2, minimum monitor units = 6, minimum leaf pairs 6, and minimum leaf end separation = 
3 cm). Beam angles with an isocenter located at the center of PTV (defined as CTV expansion 
of 1 cm superior–inferior, 0.5 cm left–right, and 0.5 cm anterior–posterior) were automatically 
determined based on the location of the lungs, PTV, and contralateral breast contours for each 
patient dataset.(22) Manual beam-angle adjustment was permitted (within 4°) if the automati-
cally generated angle restricted obtaining acceptable DVH criteria.
After completion of the script, each plan was individually optimized by adjusting the appro-
priate IMRT optimization parameters to achieve clinically acceptable DVH criteria(23) (Table 1) 
and visual acceptance by an experienced senior planner. No other optimization parameters were 
changed, to avoid variations in planning technique. Visual acceptance was based on department 
clinical practice and ensured a balanced distribution of any hotspots in the plans, an acceptable 
assessment of the 100% and 95% isodose curves compared with the DVH criteria, and ensured 
the dose was not compromised near skin surface. Qualitative visual assessment was conducted 
to confirm homogeneity of the dose distribution within the PTV, as well as ensuring high dose 
levels did not occur outside the PTV and that the maximum dose occurred within the PTV. The 
aim of the script was to automate the planning process and reduce the subjectivity of planning. 
Any additional changes required to optimize the plan were performed by the same planner for 
consistency among all datasets. After final optimization, multileaf collimator (MLC) banks 
were manually adjusted on appropriate beam segments at the anterior flash section to allow 
2 cm overshoot anteriorly. This resulted in a hybrid IMRT technique with (on average) 80% 
of the dose delivered through open beams with a 2 cm anterior overshoot and 20% of the dose 
delivered through IMRT beams.
Table 1. The DVH criteria for plan evaluation (based on RTOG guidelines and clinical experience).
Target/OAR Structure Ideal Criteria Acceptable Criteria
PTV
> 95% receives > 47.5 Gy ≥ 95% receives ≥ 45 Gy
Maximal 1 cc ≤ 53.5 Gy Maximal 1 cc ≤ 55  Gy
Seroma
> 99% receives > 47.5 Gy > 99% receives > 46 Gy
Maximal 1 cc < 55 Gy Maximal 1 cc < 57.5 Gy
Combined Lung
< 10% receives 10 Gy < 10% receives 10 Gy
Mean dose < 10 Gy Mean dose < 10 Gy
Ipsilateral Lung < 15% receives > 20 Gy < 20% receives > 20 Gy
Heart Mean < 4 Gy Mean < 5 Gy
Contralateral Breast Maximal 1 cc < 1.86 Gy Maximal 1 cc < 3.10 Gy
12  Walker et al.: MRI distortion impact on breast IMRT 12
Journal of Applied Clinical Medical Physics, Vol. 17, No. 5, 2016
E.  Dosimetric evaluation
Once plans were optimized on each distorted dataset, the beams from these plans were exported 
and then imported onto the original CT image with the beam isocenter placed at the center of 
the undistorted PTV, simulating a treatment setup position. Tangential beams were recomputed 
using fixed monitor units (MU), beam weights, and dose grid resolution. No additional optimi-
zation was performed at this stage, in order to determine the impact of the distortion. The dose 
criteria (Table 1) were then tabulated. Each of these plans was then assessed as a pass or fail 
based on DVH and visual acceptance criteria. Plans meeting the DVH and visual assessment 
criteria were generated on all 18 original (undistorted) CT images. This provided a baseline 
from which the distortion impact could be tested.
 
III. RESULTS 
A.  Residual system distortion
The maximum residual system distortions were 7.88 mm (95% below 4.67 mm) over a 500 × 
500 × 254 mm3 FOV on the 3T and 11.87 mm (95% below 4.56 mm) over a 475 × 380 × 
420 mm3 FOV on the 1T. The largest distortions were observed at the FOV edges. The target 
registration error between the capsule centers was within one voxel.
B.  Contour deformation
The average size of contoured volumes is displayed in Table 2. The maximum distortion observed 
in each contour and the DSC overlap between distorted and undistorted contours is presented 
for each distortion type, averaged across all patients. Distortion vector fields displaying where 
distortions ≥ 2 mm are shown in Fig. 2 for all three deformations, relative to the contour loca-
tions. Maximum distortions for the patient measurements (inclusive of setup errors) (Fig. 2(b)) 
were larger than the residual system distortions alone (Fig. 2(a)).
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Fig. 2. Coronal comparison of the CTV (green), contralateral breast (pink), lung (blue) and heart (red) volumes relative 
to distortions ≥ 2 mm for (a) the 3T phantom, (b) an example 3T patient dataset (incorporating patient and system related 
distortions as well as set-up uncertainties), and (c) the 1T phantom. Scales set relative to maximum distortion in (b). 
Visualization by http://smili-project.sourceforge.net/.
Table 2. Variations in the contour volumes and overlap comparisons between original and distorted contour volumes. 
Phantom data consists of residual system distortions, while patient scans also include patient-specific distortions and 
setup uncertainties.
Scanner Contour
Mean 
Undistorted CTV 
Volume ± 2σ 
(cm3)
Mean Maximum  
Distortion ± 2σ 
(mm)  
Within Contour
Mean 
DSC ± 2σ for 
Each Contour
3T phantom
CTV
(R)
(L)
796.0±737.7
485.8±641.3
3.0±1.2
2.6±0.8
0.97±0.01
0.97±0.01
Seroma
(R)
(L)
28.0±87.2
11.0±16.0
1.0±1.1
1.2±0.4
0.96±0.08
0.91±0.12
CB
(R)
(L)
974.9±774.6
585.0±515.5
3.7±1.5
2.9±0.6
0.97±0.01
0.97±0.01
Combined Lung 2462±1220 3.0±1.3 0.98±0.00
Heart 477.6±134.4 1.4±0.6 0.99±0.01
1T phantom
CTV
(R)
(L)
As above
2.9±0.5
2.5±1.4
0.97±0.01
0.95±0.02
Seroma
(R)
(L)
2.3±0.5
2.0±0.4
0.96±0.10
0.90±0.07
CB
(R)
(L)
3.4±1.2
2.8±0.5
0.96±0.01
0.96±0.02
Combined Lung 4.9±1.7 0.97±0.01
Heart 2.0±0.2 0.98±0.01
3T patient
CTV
(R)
(L)
5.9±4.6
6.6±6.9
0.94±0.02
0.91±0.06
Seroma
(R)
(L)
3.7±4.0
4.6±4.2
0.82±0.19
0.74±0.16
CB (R)(L)
6.4±3.1
7.0±4.4
0.94±0.02
0.91±0.06
Combined Lung 11.3±8.6 0.93±0.04
Heart 9.1±7.1 0.92±0.05
CB = Contralateral Breast; R = Right-sided patient; L = Left-sided patient; σ = standard deviation; DSC = Dice 
similarity coefficient.
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C.  Deformable registration validation
The mean DSC between the breast volume on the original planning CT and the patient MRI 
was 0.938 (range 0.909 – 0.964). Following registration, the mean DSC between the deformed 
planning CT and the MRI increased to 0.962 (range 0.912 – 0.980) indicating that the deformed 
CT images were well matched to the MRI.
D.  Dosimetric impact
Mean variations in DVH criteria between distorted plans optimized on the distorted dataset 
compared to that of the distorted plan recomputed on the original datasets are shown in Table 3. 
All plans optimized on either the 3T and 1T phantom distorted datasets passed both the DVH 
and visual assessment when recomputed on the original CT dataset. Of the 18 plans optimized 
on the CT datasets that were deformably registered to the 3T patient images, four right-sided 
and four left-sided patients failed the clinical tolerances when recomputed on the original dataset 
(two failed DVH, four failed visual, two failed DVH and visual assessments). Figure 3 compares 
DVHs for two patients for the combined 3T distortions (one pass, one fail), 3T systematic, and 
1T systematic distortions. Of the eight patients that were rendered clinically unacceptable based 
on our dosimetric acceptance criteria, five were imaged at the lower pixel bandwidth and three 
were imaged at the higher bandwidth.
 
Table 3. Quantitative assessment of the DVH parameters and the clinical plan acceptance. All numbers were computed 
based on dose optimized on distorted datasets less dose when recomputed on undistorted dataset.
Dose Criteria
Mean Difference
± 2σ
(3T phantom)
Mean Difference
± 2σ
(1T phantom)
Mean Difference
± 2σ
(3T patient)
Right
PTV V47.5 Gy 0.2±1.2% 0.5±1.8% 0.3±2.5%
Max 1cc -0.2±0.3 Gy 0.0±0.4 Gy 0.2±0.7 Gy
Seroma V47.5 Gy 0.1±0.8% -0.1±0.5% 0.2±1.7%
Max 1cc 0.1±0.2 Gy 0.2±0.4 Gy 0.1±0.8 Gy
Ipsilateral Lung V20 Gy -0.1±0.4% -0.5±0.9% 0.8±2.7%Heart Mean 0.0±0.3 Gy -0.0±0.1 Gy -0.0±0.3 Gy
CB Max 1 cc -0.0±0.1 Gy -0.0±0.3 Gy 0.1±0.6 Gy
Left
PTV V47.5 Gy -0.8±1.6% 0.3±1.4% -0.7±1.9%
Max 1cc -0.0±0.1 Gy 0.0±0.2 Gy 0.5±1.0 Gy
Seroma V47.5 Gy -0.5±1.6% -0.5±2.0% -0.4±1.7%
Max 1cc -0.2±0.6 Gy -0.0±0.2 Gy 0.2±0.9 Gy
Ipsilateral Lung V20 Gy -0.2±0.5% 0.3±0.6% -0.3±1.8%
Heart Mean 0.1±1.3 Gy -0.1±0.2 Gy -0.4±0.9 Gy
CB Max 1 cc -0.0±0.1 Gy -0.1±0.2 Gy 0.3±2.4 Gy
Combined Lung V20 Gy -0.1±0.2% -0.1±0.4% -0.1±0.7%
Plan pass/fail Overall 18  / 0  18  / 0  10  / 8 
CB = contralateral breast;  = plan met acceptable criteria;  = plan did not meet acceptable criteria.
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IV. DISCUSSION
This work investigated the impact of system- and patient-related distortions on MRI-based 
whole-breast IMRT planning. Results have shown that residual system distortions can vary 
greatly between two different scanners, both of which are utilized for RTP simulation. 
However, the effect of these distortions alone was found to have minimal impact on photon 
dosimetry. Residual system distortions, combined with patient-related distortions (including 
chemical shift and susceptibility), potentially have a larger impact on dosimetric variation, 
requiring consideration if utilizing patient geometry as observed on MRI in the radiotherapy 
planning process.
Most modern scanners come with the option to apply geometric correction algorithms to 
account for the gradient nonlinearities in 2D and/or 3D. Though distortions may not be com-
pletely removed, a reduction in systematic distortions is shown when applying the 2D correction 
over no correction,(6) and when applying the 3D correction over the 2D correction.(5) Patient 
Fig. 3. DVHs for two patients (left and right) showing the variation in dose coverage variation that occurs when incor-
porating different distortion factors. / = distorted plan met/did not meet criteria when recomputed on original image.
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MRIs were acquired with a vendor-supplied 2D correction algorithm as the 3D correction was 
unavailable at commencement of patient imaging. However, these images acquired with the 
2D algorithm provide a “worst case” scenario and the dosimetric impact of the 3D correction 
can be expected to be smaller.
Both the wide, closed-bore 3T and the vertical, open-bore 1T performed similarly in terms of 
dosimetric impact in terms of the residual system distortion effects as measured by phantoms. 
Despite the known increase in gradient nonlinearity distortions with increased distance from 
isocenter, residual distortions of laterally positioned breasts did not adversely impact dosimetry. 
Maximum distortion values observed within contoured regions for the 3T patient-distorted 
datasets were on average 3.8 times greater than those corresponding to the phantom data alone, 
indicating that the patient-induced distortions (and associated setup errors) were larger than 
those of the residual system distortions.
Datasets incorporating both patient- and residual system-related distortions were found 
to have greater dosimetric impact than the residual system distortions alone, and therefore 
these will need to be considered if utilizing MRI in the whole-breast radiotherapy planning 
process. On average, plans generated on patient-distorted images were more inhomogeneous 
with increased hot and cold regions when recomputed on the original CT geometry. The prob-
ability of a distorted plan passing or failing did not correlate with laterality, extent of contour 
distortion, patient size, or pixel bandwidth. Placing a patient within the magnetic field leads to 
geometric distortions arising from chemical shift and susceptibility artefacts. These effects are 
the result of variations in the magnetic properties of tissues within the body. This is an issue 
for breast imaging where there are interfaces between glandular tissue, fatty tissue, muscle, 
ribs, lungs, patient surface, and air. The chemical shift due to difference in water and fat sig-
nals is 440 Hz at 3T (220 Hz at 1.5T), resulting in field perturbations of 3.5 parts per million 
(ppm). This corresponds to a geometric shift of 2 pixels/4 mm in the higher bandwidth scans 
(up to 4 pixels/8 mm in the lower bandwidth scans) for this study. Field perturbations due to 
susceptibility between different tissues can be as large as 6 ppm.(4) Increasing the BW further 
could have benefit in reducing the susceptibility effects, though this would come at the expense 
of the SNR, which may limit clinical utility. These preliminary results show that, even in high 
BW scans, some plans failed to meet the dosimetric criteria.
These findings vary from investigations on the prostate and brain, where system and patient 
distortions were not found to have a significant impact on dosimetry.(12-14) However, these 
studies were conducted on scanners of lower field strengths (with concomitant reduction in 
patient effects(24)) and the anatomical regions of interest are located in the center of the FOV 
where system effects are negligible. Additionally, these sites generally have smaller air-tissue 
interface regions near the target. In contrast, our current study can be expected to produce a 
greater problem owing to the peripheral location of breast tissue and higher field strength.
While vendor-supplied distortion corrections are essential to minimize the dosimetric impact 
of system-related distortions, our results suggest that patient-specific correction methods may 
be helpful in reducing the dosimetric impact of geometric distortions on the planning process. 
Techniques such as B0 mapping
(8) or the acquisition of two images of reversed frequency-encode 
direction(9) that could reduce patient susceptibility effects were not part of the acquisition 
protocol since this data was acquired retrospectively. This will be investigated in future work.
Due to the retrospective dataset utilized for this study, separating the errors due to the 
patient distortion from those due to setup variations is challenging. As such, a number of 
techniques were utilized to minimize the impact of setup errors on this study, as is performed 
clinically within the department for patient treatments. MRI and CT images were acquired 
on the same day to reduce variations due to changing patient anatomy over time. All patient 
setup and imaging was performed and recorded by an experienced radiation therapist to 
ensure consistent setup between both imaging modalities and treatment. The patient CT and 
MRIs were rigidly registered prior to deformable registration to reduce setup errors to within 
17  Walker et al.: MRI distortion impact on breast IMRT 17
Journal of Applied Clinical Medical Physics, Vol. 17, No. 5, 2016
the tolerance values to minimize dosimetric variations. Systematic and random setup errors 
for whole-breast  radiotherapy have been reported as 1–2 mm and 2–3 mm, respectively.(25) 
Harron et al.(26) reported that translational shifts of 5 mm would result in a less than 5% varia-
tion in the target volume receiving 95% and 107% of the prescribed dose. A study by George 
et al.(27) investigated the dosimetric impact on breast radiotherapy for no, shallow, normal, 
and heavy breathing (0, 0.5, 1, and 2 mm displacement, respectively). They found that, when 
compared to no breathing motion, the PTV D95 was reduced by 5%, 8%, and 10% for shallow, 
normal, and heavy breathing, respectively. DVH variations across all three datasets within our 
study were less than these reported setup values. The hybrid IMRT technique utilized for this 
study (80% dose through open beams, 20% dose through IMRT beams) has also been found 
to the most be robust treatment technique when dealing with setup errors for whole-breast 
radiotherapy.(25,28)
The image registration presents another potential study limitation since the plans are being 
generated on manipulated images and structures. The registration accuracy was within a voxel-
size within the chest region of interest. When registering the patient CT and MRIs, there were 
some differences around the patients’ arms due to slight positional variations. Since these were 
well out of the dose calculation region, these variations were not considered. Image registration 
is also a point of consideration when utilizing both CT and MRIs in the planning process.(29)
Distortion mitigation must be addressed if moving towards MRI-only planning where a 
patient CT would not be available for reference. Although our results showed the influence of 
the scanners alone had minimal impact, it is important to quantify the geometric accuracy of 
each system. This is especially important for future MRI-linac treatment units where magnet 
and gradient specifications may be worse, as well as on higher field-strength systems where 
the patient effects will be more problematic.
The results presented are specific to whole-breast IMRT treatments. While breast treatment 
volumes extend into FOV regions where geometric distortions are largest, the dosimetric impact 
from residual system distortions alone appear small. Since breast is a relatively homogeneous 
tissue structure, the photon interactions may be more forgiving of these geometric variations. In 
anatomical sites with multiple structures, the dosimetric impact of residual distortions may be 
larger due to more complex planning methods and tissue variations. These factors may be more 
important when considering partial-breast radiotherapy and will be considered in the future. 
In a partial-breast treatment, the dosimetric impact may be increased with smaller treatment 
volumes and more targeted fields.
 
V. CONCLUSIONS
Combined MRI-systematic and patient-related distortions may result in unacceptable dosimetric 
variations for whole-breast IMRT if considering MRI-only radiotherapy treatment planning. 
Residual system distortions alone had minimal impact on the dosimetry variations for two dif-
ferent scanners of differing configurations and field strengths. Improved methods to account 
for patient-specific distortion would be beneficial to minimize dosimetric variations if using 
MRI alone in the treatment planning process.
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